News

Published on 10 Nov 2023 on Insider Monkey via Yahoo Finance

Lantern Pharma Inc. (NASDAQ:LTRN) Q3 2023 Earnings Call Transcript


Article preview image

Lantern Pharma Inc. (NASDAQ:LTRN) Q3 2023 Earnings Call Transcript November 9, 2023

Operator: Good afternoon, and welcome to our Third Quarter 2023 Earnings Call. As a reminder, this call is being recorded and all attendees are in a listen-only mode. We will open the call for questions and answers after our management’s presentation. A webcast replay of today’s conference call will be available on our website at lanternpharma.com shortly after the call. We issued a press release after market close today summarizing our financial results and progress across the company for the third quarter ended September 30, 2023. A copy of this release is available through our website at lanternpharma.com where you will also find a link to the slides management will be referencing on today’s call. We would like to remind everyone that remarks about future expectations, performance, estimates and prospects constitute forward-looking statements for purposes of safe harbor provisions under the Private Securities Litigation Reform Act of 1995.

Lantern Pharma cautions that these forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially from those anticipated. A number of factors could cause actual results to differ materially from those indicated by forward-looking statements, including results of clinical trials and the impact of competition. Additional information concerning factors that could cause actual results to differ materially from those in the forward-looking statements can be found in our annual report on Form 10-K for the year ended December 31, 2022, which is on file with the SEC and available on our website. Forward-looking statements made on this conference call are as of today, November 8, 2023, and Lantern Pharma does not intend to update any of these forward-looking statements to reflect events from circumstances that occur after today, unless required by law.

NASDAQ.LTRN price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Lantern Pharma Inc. (NASDAQ:LTRN) Q4 2023 Earnings Call Transcript

Lantern Pharma Inc. (NASDAQ:LTRN) Q4 2023 Earnings Call Transcript March 18, 2024 Lantern Pharma ...

Insider Monkey via Yahoo Finance 19 Mar 2024

11 Best Artificial Intelligence Stocks Under $20 According To Hedge Funds

In this article, we discuss 11 best artificial intelligence stocks under $20. If you want to skip...

Insider Monkey via Yahoo Finance 7 Mar 2024

Lantern Pharma Inc. (NASDAQ:LTRN) Q3 2023 Earnings Call Transcript

Lantern Pharma Inc. (NASDAQ:LTRN) Q3 2023 Earnings Call Transcript November 9, 2023 Operator: Goo...

Insider Monkey via Yahoo Finance 10 Nov 2023

3 AI Stocks That Still Trade Under $10 Per Share

The artificial intelligence (AI) boom is far from over. For example let’s look at Nvidia (NASDAQ:...

InvestorPlace via Yahoo Finance 28 Aug 2023

3 AI Stocks You’ll Regret Not Buying Soon

Artificial intelligence (AI) will have a profound impact on the medical industry, where it could ...

InvestorPlace via Yahoo Finance 8 Aug 2023

Lantern Pharma said it had no exposure to SVB or Signature Bank, after stock plunged last week

Lantern Pharma Inc. LTRN confirmed Monday that it, or any of its subsidiaries, had no exposure to...

MarketWatch 13 Mar 2023

10 Best Artificial Intelligence Stocks Under $10

In this article, we discuss the 10 best artificial intelligence stocks under $10. If you want to ...

Insider Monkey via Yahoo Finance 2 Dec 2022

Lantern Pharma Touts Encouraging Positive Efficacy For Pancreatic Cancer Candidate

Lantern Pharma Inc (NASDAQ: LTRN) will present preclinical data on the in vivo efficacy of its dr...

Benzinga via Yahoo Finance 14 Sep 2022

The Week Ahead In Biotech (March 6-12): Quiet Week On Tap With Earnings Season Reaching It Final Leg

Biotech stocks reversed course in the week ending March 4, as the Ukrainian crisis weighed down o...

Benzinga 6 Mar 2022

The Daily Biotech Pulse: J&J Files For Booster Dose Authorization, Gemini Restructures, Strata Skin...

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks

Benzinga via Yahoo Finance 5 Oct 2021